NCT07191730
- Conditions
- Breast Diseases, Breast Neoplasms, Cardiotoxicity, +13 more
- Locations
-
- CHU de Caen Caen, France
Clinical trial condition
Cardiotoxicity
Explore clinical trials studying Cardiotoxicity. Study availability and eligibility vary by location and protocol.
84 public trials
28 recruiting studies
Cardiotoxicity trial results
NCT07382141
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +6 more
- Locations
-
- IRCCS - AOU di Bologna -Policlinico di Sant'Orsola UOC Pediatria Bologna, Italy
- IRCCS AOU di Bologna -Policlinico di Sant'Orsola UO Cardiochirurgia pediatrica e dell'età evolutiva Bologna, Italy
- IRCCS AOU di Bologna -Policlinico di Sant'Orsola UO Oncoematologia Pediatrica Bologna, Italy
- IRCCS AOU di Bologna Policlinico di Sant'Orsola UO Cardiologia Pediatria e dell'età evolutiva Bologna, Italy
NCT06595147
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +15 more
- Locations
-
- University of Alberta Edmonton, Alberta, Canada
NCT05023785
- Conditions
- Behavior, Cancer, Cardiotoxicity, +10 more
- Locations
-
- University Health Network Toronto, Ontario, Canada
NCT03418961
- Conditions
- Brain Diseases, Brain Neoplasms, Breast Diseases, +22 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States
Recruiting
Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast Cancer
NCT05406635
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +7 more
- Locations
-
- Aalborg University Hospital Aalborg, Denmark
- Rigshospitalet Copenhagen, Denmark
- Herlev University Hospital Herlev, Denmark
- Odense University Hospital Odense, Denmark
Recruiting
Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
NCT03711110
- Conditions
- Antineoplastic Agents, Blood Protein Disorders, Breast Diseases, +39 more
- Locations
-
- Hospital Clínico Universitario de Santiago de Compostela Santiago de Compostela, A Coruña, Spain
- Hospital de Galdakao-Usansolo Galdakao, Vizcaya, Spain
- Hospital Universitario Vall d´Hebron Barcelona, Spain
- Hospital Universitario Reina Sofía Córdoba, Spain
NCT05465031
- Conditions
- Angiotensin II Type 1 Receptor Blockers, Angiotensin Receptor Antagonists, Antihypertensive Agents, +24 more
- Locations
-
- Regional Cancer Centre in Opole Opole, Opole Voivodeship, Poland
- Maria Sklodowska-Curie Institute - Oncology Centre (MSCI), Gliwice Branch Gliwice, Silesian Voivodeship, Poland
- Silesian Center for Heart Diseases Zabrze, Silesian Voivodeship, Poland
- Holy Cross Cancer Centre, Cardio-Oncology Division Kielce, Świętokrzyskie Voivodeship, Poland
NCT06853951
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +6 more
- Locations
-
- Faculty of Pharmacy, Ain Shams University Cairo, Egypt
- Faculty of Pharmacy, Ain Shams University Cairo, Egypt
NCT04262830
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +9 more
- Locations
-
- Rady Children's Hospital San Diego, California, United States